The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 309 participants.
Also called NCT03120299
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 309 participants
- Registry
-
NCT03120299
-
- Other papers using this trial's data
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03120299. Randomized; quadruple masking; primary purpose treatment. Start 2017-05-01 (actual); primary completion 2021-03-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Hypertriglyceridemia
- Intervention (Drug)
- Omega-3 fatty acid
- Intervention (Drug)
- Placebos
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
Record details
- Record id
cardio:ct-nct03120299- Content hash
8c1b04f09b2591f5ee9d93fd4a2723bf89e0d68720e03dee0baeb36e38f9475a